- freely available
Int. J. Mol. Sci. 2013, 14(11), 21781-21789; doi:10.3390/ijms141121781
Abstract: Two new eunicellin-based diterpenoids, cladieunicellins K (1) and L (2), were isolated from an octocoral Cladiella sp. The structures of 1 and 2 were elucidated by spectroscopic methods and 2 exhibited moderate cytotoxicity towards the MOLT-4 human leukemia.
Eunicellin-based diterpenoids, such as eleutherobin, have been proven to be potential anticancer agents . In our continuing research on the chemical constituents of octocorals belonging to the genus Cladiella collected off the waters of Taiwan and Indonesia, various eunicellin-related analogues have been isolated [2–7]. Recently, two new eunicellin-type diterpenoids, cladieunicellins K (1) and L (2) were isolated from an octocoral identified as Cladiella sp. (Scheme 1). In this paper, we describe the isolation, structure determination and cytotoxicity of eunicellins 1 and 2.
2. Results and Discussion
Cladieunicellin K (1) was isolated as colorless oil and its molecular formula was established as C24H38O6 (6° of unsaturation) by the HRESIMS at m/z 445.2564 (calcd for C24H38O6Na, 445.2566). The IR absorptions at υmax 3388 (broad) and 1736 cm−1 revealed the presence of hydroxy and carbonyl functionalities. The 13C spectrum of 1 showed 24 carbon signals (Table 1), which were assigned with the assistance of the DEPT spectrum to five methyls, six sp3 methylenes, an sp2 methylene, seven sp3 methines (including three oxymethines), two sp3 oxygenated quaternary carbons and three sp2 quaternary carbons (including two carbonyls). The 13C resonances at δC 213.8 and 172.1 demonstrated the presence of a ketonic carbonyl and an ester carbonyl, respectively. The ester carbonyl was identified as an n-butyrate carbonyl by the presence of seven contiguous protons at δH 1.01 (3H, t, J = 7.6 Hz), 1.72 (2H, sext, J = 7.6 Hz) and 2.36 (2H, t, J = 7.6 Hz). From the 13C NMR data, an exocyclic carbon-carbon double bond was deduced from the signals at δC 116.6 (CH2) and 144.4 (C), and confirmed by two olefin proton signals at δH 4.86 (1H, d, J = 1.6 Hz) and 5.12 (1H, d, J = 1.6 Hz) in the 1H NMR spectrum. Comparison of the 13C NMR and DEPT spectra with the molecular formula indicated that there must be two exchangeable protons, requiring the presence of two hydroxy groups. From the above data, 1 had to be tricyclic to account for the three degrees of unsaturation.
From the 1H–1H COSY spectrum of 1 (Table 1), the spin systems of H2-4/H2-5/H-6 and H-10/H-1 were differentiated. These data, together with the HMBC correlations among H-1/C-3, -9, -10; H-2/C-1, -3, -10; H2-4/C-2, -3, -5, -6; H2-5/C-3, -4, -6, -7; H-6/C-7, -8; H-8/C-6, -7, -9; and H-10/C-1, -9, established the connectivity from C-1 to C-10 in the 10-membered ring (Table 1). The 1-isopropyl-4-methylenecyclohexane ring, which is fused to the 10-membered ring at C-1 and C-10, was elucidated by the 1H–1H COSY correlations between H-1/H-14/H2-13/H-12 and H-14/H-18/H3-19 (H3-20) and by the HMBC correlations between H-1/C-14; H-2/C-14; H-10/C-11, -12, -14, -17; H2-13/C-1; and H2-17/C-10. The isopropyl group was positioned at C-14 from the HMBC correlations between H-1/C-14; H-18/C-13; and by the mutual and common HMBC correlations: H3-19/C-14, -18, -20; and H3-20/C-14, -18, -19. An exocyclic carbon-carbon double bond at C-11 was confirmed by the HMBC correlations between H2-17/C-10, -11, -12. The ether bridge between C-2 and C-6 was supported by the HMBC correlations between H-2/C-6 and H-6/C-2. The hydroxy proton signal at δH 6.02 was revealed by its 1H–1H COSY and HMBC correlations to δH 4.25 (H-12) and δC 70.3 (CH-12), respectively, indicating its attachment to C-12. The location of a hydroxy group at C-7, an oxygenated quaternary carbon, was confirmed by the HMBC correlations between a hydroxy proton at δH 4.59 and C-7, -8 and C-16. Thus, the remaining n-butyrate group was at C-3, an oxygenated quaternary carbon which bonded to the C-15 tertiary methyl and was confirmed by the HMBC correlations between H3-15/C-2, -3, -4.
Most naturally occurring eunicellin analogues from soft corals belonging to the genus Cladiella have H-1 and H-10 in the β-orientation . The relative configuration of 1 was elucidated mainly from a NOESY spectrum (Scheme 2) and that obtained from vicinal proton coupling constant analysis. In the NOESY experiment, H-1 correlated with H-10 and H3-20, but no correlation was found between H-10 and H3-20, indicating that H-1 was β-oriented and positioned on the axial direction; and H-10 and the isopropyl group were β-oriented and positioned on the equatorial directions in the cyclohexane ring of 1. The coupling constants between H-12 and C-13 methylene protons (J = 2.8, 2.8 Hz) indicated that H-12 was positioned on equatorial direction and possessed a β-orientation in the cyclohexane ring of 1. No coupling constant was detected between H-1 and H-2, indicating the dihedral angle between H-1 and H-2 is 90° and H-2 should be α-oriented. The C-15 methyl showed correlations with H-1, H-2 and H-4α/β, but not with H-10, demonstrating the n-butyrate group at C-3 was β-oriented. It was found that one of the methylene protons at C-8 (δH 2.79) exhibited a correlation with H-10, and, therefore, it was assigned as H-8 β, and the other C-8 proton (δH 2.08) as H-8α. The correlations between H3-16/H-8α and H-6/H3-16, suggested the α-orientation of Me-16 and H-6. Based on the above findings, the structure of 1 was elucidated and the chiral carbons for 1 were assigned as 1R*, 2R*, 3R*, 6R*, 7R*, 10R*, 12S* and 14R*.
Cladieunicellin L (2) was isolated as colorless oil that gave a molecular ion [M + Na]+ at m/z 519.2567 in the HRESIMS, indicating the molecular formula C26H40O9 (calcd for C26H40O9Na, 519.2570) and implying seven degrees of unsaturation. The IR spectrum of 2 showed bands at υmax 3458 (broad) and 1731 cm−1, consistent with the presence of hydroxy and ester groups. Comparison of the 13C and DEPT spectral data with the molecular formula indicated that there must be two exchangeable protons, which required the presence of two hydroxy groups. Based on the 1H and 13C NMR spectra (Table 2), compound 2 was found to possess an exocyclic carbon-carbon double bond (δH 5.20, 2H, br s; δC 117.2, CH2; 143.1, C) and three acetoxy (δH 2.07, 2.09, 2.10, each 3H × s, methyls; δC 21.4, 21.6, 22.4, 3 × methyls; δC 169.5, 170.4, 171.9, 3 × carbonyls) groups. From the above findings, metabolite 2 was established to be a tricyclic diterpenoid. In addition, a suite of resonances of proton signals at δH 2.30 (1H, ddd, J = 10.4, 7.2, 1.2 Hz), 3.71 (1H, d, J = 1.2 Hz), 4.03 (1H, dd, J = 9.2, 6.4 Hz) and 3.35 (1H, dd, J = 7.2, 6.4 Hz), and carbon signals at δC 44.3 (CH), 91.3 (CH), 82.5 (CH) and 51.0 (CH), indicated the presence of a tetrahydrofuran moiety.
From the 1H–1H COSY spectrum of 2 (Table 2), it was possible to identify the spin systems among H-1/H-2, H2-4/H2-5/H-6, H-8/H-9/H-10/H-1/H-14/H2-13/H-12 and H-14/H-18/H3-19 (H3-20). These data, together with the key HMBC correlations between protons and quaternary carbons of 2 (Table 2), such as H-2, H2-4, H2-5, H3-15/C-3; H2-5, H-6, H3-16/C-7; and H-9, H-10, H2-17/C-11, permitted elucidation of the carbon skeleton. The ether bridge between C-2 and C-9 was supported by the HMBC correlations between H-2/C-9 and H-9/C-2. The locations of acetoxy groups in 2 were confirmed by the HMBC correlations between H-6 (δH 5.73) and H-12 (δH 5.46) and the acetate carbonyls at δC 171.9 and 170.4, respectively. The hydroxy group at C-7, an oxygenated quaternary carbon, was elucidated by the HMBC correlations between a hydroxy proton at δH 2.36 and C-7, -8 and C-16. The oxymethine proton signal at δH 3.49 was revealed by its 1H–1H COSY correlation to δH 4.03 (H-9) and 2.09 (OH-8), indicating a hydroxy group at C-8. Thus, the remaining acetate group in 2 should be positioned at C-3.
The chiral carbons in the cyclohexane ring of 2 were found to possess the same relative configurations (1R*, 10R*, 12S* and 14R*) as those of 1 by its NOESY correlations (Scheme 3) and vicinal proton constants analysis. The dihedral angle between H-1 and H-2 was inferred to be approximately 90° by a small coupling constant (J = 1.2 Hz) between these two protons. Moreover, H-2 should be α-oriented. H-8 exhibited correlations with H-10 and H3-16, but not with H-9, suggesting that H-9 and the hydroxy groups at C-7 and C-8 were α-oriented. H-6 correlated with 7-OH, indicating the 6-acetoxy group was β-oriented. H3-15 showed correlations with H-1, H-2 and H-4α/β, but not with H-10, demonstrating that the 3-acetoxy group was β-oriented. Based on the above findings, the structure of 2 was elucidated and the chiral carbons for 2 were assigned as 1R*, 2R*, 3R*, 6S*, 7S*, 8R*, 9S*, 10R*, 12S* and 14R*.
Cytotoxicity of compounds 1 and 2 toward HL-60 (human promyelocytic leukemia) and MOLT-4 (human acute T lymphoblastic leukemia) cells was studied, and the results are shown in Table 3. These data showed that cladieunicellin L (2) exhibited moderate cytotoxicity towards the MOLT-4 cells.
3. Experimental Section
3.1. General Experimental Procedures
Optical rotations were measured at a Jasco P-1010 digital polarimeter (Japan Spectroscopic Corporation, Tokyo, Japan). Infrared spectra were recorded on a Varian Diglab FTS 1000 FT-IR spectrometer (Varian Inc., Palo Alto, CA, USA); peaks are reported in cm−1. NMR spectra were recorded on a Varian Mercury Plus 400 NMR spectrometer (Varian Inc., Palo Alto, CA, USA) using the residual CHCl3 signal (δH 7.26 ppm) as the internal standard for 1H NMR and CDCl3 (δC 77.1 ppm) for 13C NMR. Coupling constants (J) are given in Hz. ESIMS and HRESIMS were recorded using a Bruker APEX II mass spectrometer (Bruker, Bremen, Germany). Column chromatography was performed on silica gel (230–400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F254 (0.25 mm, Merck, Darmstadt, Germany); spots were visualized by spraying with 10% H2SO4 solution followed by heating. The normal phase HPLC (NP-HPLC) was performed using a system comprised of a Hitachi L-7110 pump (Hitachi Ltd., Tokyo, Japan) and a Rheodyne 7725 injection port (Rheodyne LLC, Rohnert Park, CA, USA). Two normal phase columns (Supelco Ascentis® Si Cat #:581515-U, 25 cm × 21.2 mm, 5 μm; 581514-U, 25 cm × 10 mm, 5 μm, Sigma-Aldrich. Com., St. Louis, MO, USA) were used for NP-HPLC. The reverse phase HPLC (RP-HPLC) was performed using a system comprised of a Hitachi L-7100 pump (Hitachi Ltd., Tokyo, Japan), a Hitachi L-2455 photodiode array detector (Hitachi Ltd., Tokyo, Japan), a Rheodyne 7725 injection port (Rheodyne LLC, Rohnert Park, CA, USA) and a reverse column (Varian Polaris C18-A, 250 mm × 10 mm, 5 μm; Varian Inc., Palo Alto, CA, USA) were used for RP-HPLC.
3.2. Animal Material
Specimens of the octocoral Cladiella sp.  were collected by hand using scuba equipment off the coast of Penghu Archipelago, Taiwan in September 2011, and stored in a freezer (−20 °C) until extraction. A voucher specimen (NMMBA-TWSC-11011) was deposited in the National Museum of Marine Biology and Aquarium, Taiwan.
3.3. Extraction and Isolation
Specimens of the soft coral Cladiella sp. (wet weight 1.25 kg, dry weight 457 g) were minced and extracted with ethyl acetate (EtOAc). The EtOAc extract left after removal of the solvent (12.4 g) was separated by silica gel and eluted using n-hexane/EtOAc in a stepwise fashion from 100:1–pure EtOAc to yield 16 fractions A–P. Fraction N was chromatographed on silica gel, using a mixture of n-hexane and acetone in a stepwise fashion from 6:1–pure acetone to obtain 15 subfractions N1–N15. Fraction N4 was repurified by NP-HPLC, using a mixture of n-hexane and acetone (10:1, flow rate: 2.0 mL/min) to yield seven subfractions N4A–N4G. Fraction N4E was further separated by RP-NPLC, using a mixture of methanol and water (8:2, flow rare: 1.0 mL/min) to yield cladieunicellin K (1) (1.1 mg, tR = 24 min). The residue of fraction N11 was separated by NP-HPLC, using a mixture of n-hexane and acetone (3:1, flow rate: 2.0 mL/min) to obtain cladieunicellin L (2) (2.8 mg, tR = 110 min).
Cladieunicellin K (1): colorless oil; ; IR (neat) νmax 3388, 1736 cm−1; 1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data, see Table 1; ESIMS: m/z 445 (M + Na)+; HRESIMS: m/z 445.2564 (calcd for C24H38O6Na, 445.2566).
Cladieunicellin L (2): colorless oil; ; IR (neat) νmax 3458, 1731 cm−1; 1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data, see Table 2; ESIMS: m/z 519 (M + Na)+; HRESIMS: m/z 519.2567 (calcd for C26H40O9Na, 519.2570).
3.4. Cytotoxicity Testing
Cytotoxicity of compounds 1 and 2 was assayed with a modification of the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] colorimetric method according to previously described procedures [10,11].
Two new eunicellin-based diterpenoids, cladieunicellins K (1) and L (2), were isolated from the soft coral Cladiella sp. Compound 2 showed moderate cytotoxicity toward the MOLT-4 leukemia. Thus, compound 2 could be promising a bioactive agent and may warrant further biomedical investigation.
|Position||δH (J in Hz)||δC, Multiple||1H–1H COSY||HMBC|
|1||2.30 dd (12.0, 4.8)||55.5, CH||H-10, H-14||C-3, -9, -10, -14|
|2||3.96 s||77.5, CH||n.o. a||C-1, -3, -6, -10, -14, -15|
|4||2.98 ddd (13.6, 4.0, 2.0)|
|27.5, CH2||H2-5||C-2, -3, -5, -6|
|5||1.68 m; 1.34 m||20.5, CH2||H2-4, H-6||C-3, -4, -6, -7|
|6||3.86 dd (12.0, 6.4)||80.2, CH||H2-5||C-2, -7, -8|
|8||2.79 d (12.0)|
2.08 d (12.0)
|47.7, CH2||C-6, -7, -9, -16|
|10||4.41 d (4.8)||57.5, CH||H-1||C-1, -9, -11, -12, -14, -17|
|12||4.25 ddd (10.4, 2.8, 2.8)||70.3, CH||H2-13, OH-12||n.o.|
|13||2.02 m; 1.26 m||34.4, CH2||H-12, H-14||C-1, -11, -12|
|14||2.23 dddd (12.0, 12.0, 2.4, 2.4)||32.0, CH||H-1, H2-13, H-18||n.o.|
|15||1.55 s||23.4, CH3||C-2, -3, -4|
|16||1.16 s||22.9, CH3||C-6, -7, -8|
|17||5.12 d (1.6); 4.86 d (1.6)||116.6, CH2||C-10, -11, -12|
|18||1.98 m||27.0, CH||H-14, H3-19, H3-20||C-13, -19|
|19||1.02 d (6.8)||21.6, CH3||H-18||C-14, -18, -20|
|20||0.70 d (6.8)||14.6, CH3||H-18||C-14, -18, -19|
|1′ 2′ 3′ 4′||2.36 t (7.6)||37.7, CH2||H2-3′||C-1′, -3′, -4′|
|1.72 sext (7.6)||18.6, CH2||H2-2′, H3-4′||C-1′, -2′, -4′|
|1.01 t (7.6)||13.7, CH3||H2-3′||C-2′, -3′|
|7-OH||4.59 s||C-7, -8, -16|
|12-OH||6.02 d (10.4)||H-12||C-12|
an.o. = not observed.
|Position||δH (J in Hz)||δC, Multiple||1H–1H COSY||HMBC|
|1||2.30 ddd (10.4, 7.2, 1.2)||44.3, CH||H-2, H-10, H-14||C-9, -10, -13, -14|
|2||3.71 d (1.2)||91.3, CH||H-1||C-1, -3, -9, -10, -14, -15|
|4||2.51 dd (14.8, 8.4); 1.99 m||34.6, CH2||H2-5||C-2, -3, -5, -6, -15|
|5||1.63 m; 1.49 m||28.5, CH2||H2-4, H-6||C-3, -4, -6, -7, -16|
|6||5.73 dd (6.8, 1.6)||81.7, CH||H2-5||C-4, -5, -7, -16, C=O|
|8||3.49 dd (10.8, 9.2)||79.7, CH||H-9, OH-8||C-9, -10|
|9||4.03 dd (9.2, 6.4)||82.5, CH||H-8, H-10||C-2, -8, -11|
|10||3.35 dd (7.2, 6.4)||51.0, CH||H-1, H-9||C-1, -8, -9, -11, -12, -14, -17|
|12||5.46 dd (4.8, 2.8)||73.4, CH||H2-13||C-10, -14, -17, C=O|
|13||1.95 m; 1.36 m||28.8, CH2||H-12, H-14||C-12, -14|
|14||1.67 m||37.2, CH||H-1, H2-13, H-18|
|15||1.43 s||22.9, CH3||C-2, -3, -4|
|16||1.30 s||18.5, CH3||C-6, -7, -8|
|17||5.20 br s||117.2, CH2||C-10, -11, -12|
|18||1.81 m||28.7, CH||H-14, H3-19, H3-20||n.o. a|
|19||0.96 d (6.8)||21.8, CH3||H-18||C-14, -18, -20|
|20||0.82 d (6.8)||15.7, CH3||H-18||C-14, -18, -19|
|3-OAc||2.10 s||169.5, C|
|6-OAc||2.09 s||171.9, C|
|12-OAc||2.07 s||170.4, C|
|7-OH||2.36 s||C-7, -8, -16|
|8-OH||2.09 d (10.8)||H-8||C-8|
an.o. = not observed.
|Compounds||Cell lines IC50 (μM)|
aDoxorubicin was used as a positive control.NA = not active at 20 μM for 72 h.
This research was supported by grants from the National Dong Hwa University; the National Museum of Marine Biology and Aquarium; the Asia-Pacific Ocean Research Center, National Sun Yat-sen University; and the National Science Council (Grant No. NSC 102-2325-B-291-001 and 101-2320-B-291-001-MY3), Taiwan, awarded to P.-J.S.
Conflicts of Interest
The authors declare no conflict of interest.
- Long, B.H.; Carboni, J.M.; Wasserman, A.J.; Cornell, L.A.; Casazza, A.M.; Jensen, P.R.; Lindel, T.; Fenical, W.; Fairchild, C.R. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (taxol®). Cancer Res 1998, 58, 1111–1115. [Google Scholar]
- Chen, Y.-H.; Tai, C.-Y.; Hwang, T.-L.; Weng, C.-F.; Li, J.-J.; Fang, L.-S.; Wang, W.-H.; Wu, Y.-C.; Sung, P.-J. Cladielloides A and B: New eunicellin-type diterpenoids from an Indonesian octocoral Cladiella sp. Mar. Drugs 2010, 8, 2936–2945. [Google Scholar]
- Chen, Y.-H.; Tai, C.-Y.; Kuo, Y.-H.; Kao, C.-Y.; Li, J.-J.; Hwang, T.-L.; Fang, L.-S.; Wang, W.-H.; Sheu, J.-H.; Sung, P.-J. Cladieunicellins A–E, new eunicellins from an Indonesian soft coral Cladiella sp. Chem. Pharm. Bull 2011, 59, 353–358. [Google Scholar]
- Tai, C.-Y.; Chen, Y.-H.; Hwang, T.-L.; Fang, L.-S.; Wang, W.-H.; Liu, M.-C.; Su, J.-H.; Wu, Y.-C.; Sung, P.-J. Cladielloides C and D: Novel eunicellin-based diterpenoids from an Indonesian octocoral Cladiella sp. Bull. Chem. Soc. Jpn 2011, 84, 531–536. [Google Scholar]
- Chen, Y.-H.; Tai, C.-Y.; Su, Y.-D.; Chang, Y.-C.; Lu, M.-C.; Weng, C.-F.; Su, J.-H.; Hwang, T.-L.; Wu, Y.-C.; Sung, P.-J. Discovery of new eunicellins from an Indonesian octocoral Cladiella sp. Mar. Drugs 2011, 9, 934–943. [Google Scholar]
- Chen, Y.-H.; Hwang, T.-L.; Su, Y.-D.; Chang, Y.-C.; Chen, Y.-H.; Hong, P.-H.; Hu, L.-C.; Yen, W.-H.; Hsu, H.-Y.; Huang, S.-J.; et al. New 6-hydroxyeunicellins from a soft coral Cladiella sp. Chem. Pharm. Bull 2012, 60, 160–163. [Google Scholar]
- Chen, Y.-H.; Tai, C.-Y.; Hwang, T.-L.; Sung, P.-J. Cladieunicellin H, a new hemiketal eunicellin-based diterpenoid from the octocoral Cladiella sp. Nat. Prod. Commun 2012, 7, 481–484. [Google Scholar]
- Radhika, P. Chemical constituents and biological activities of the soft corals of genus Cladiella: A review. Biochem. Syst. Ecol 2006, 34, 781–789. [Google Scholar]
- Fabricius, K.; Alderslade, P. Soft Corals and Sea Fans–A Comprehensive Guide to the Tropical Shallow-Water Genera of the Central-West Pacific, the Indian Ocean and the Red Sea, 1st ed; Australian Institute of Marine Science: Townsville, QLD, Australia, 2001; pp. 84–85. [Google Scholar]
- Alley, M.C.; Scudiero, D.A.; Monks, A.; Hursey, M.L.; Czerwinski, M.J.; Fine, D.L.; Abbott, B.J.; Mayo, J.G.; Shoemaker, R.H.; Boyd, M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988, 48, 589–601. [Google Scholar]
- Scudiero, D.A.; Shoemaker, R.H.; Paull, K.D.; Monks, A.; Tierney, S.; Nofziger, T.H.; Currens, M.J.; Seniff, D.; Boyd, M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988, 48, 4827–4833. [Google Scholar]
© 2013 by the authors; licensee MDPI, Basel, Switzerland This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).